SCHEMBL13487349

SCHEMBL13487349

CC1(C)c2ccccc2-c2ccc(-c3ccc4c(-c5ccc(F)cc5)c5ccccc5c(-c5cccc6c5-c5ccccc5C6(C)C)c4c3)cc21

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 15/20 0.41
PGR P06401 2/20 0.33
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487103 0.92 PDK2 (0.37) PDK2PGRACHE
SCHEMBL13488114 0.92 PDK2 (0.46) PDK2PGRACHE
SCHEMBL13487270 0.89 PIK3CD (0.34) PDK2PGRACHE
SCHEMBL13487740 0.88 PDK2 (0.43) PDK2PGRACHE
SCHEMBL13487891 0.88 PDK2 (0.46) PDK2PGRACHE
SCHEMBL13488552 0.88 PDK2 (0.35) PDK2
SCHEMBL13487379 0.88 PDK2 (0.37) PDK2
SCHEMBL10153428 0.88 PDK2 (0.49) PDK2PGRACHE
SCHEMBL10153289 0.88 PDK2 (0.49) PDK2PGRACHE
SCHEMBL13487167 0.87 MCL1 (0.33) PDK2PGRACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
EP-2108689-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-10-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 PDK2 1456/4885PGR 4215/4885ACHE 1095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.